The effect of carnitin supplementation in hemodialysis patients

The effect of carnitine supplementation on adiponectin and leptin total antioxidant capacity concentrations in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013070913160N2

Enrollment

Registered

2013-11-06

Start date

2013-10-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodilysis. Care involving dialysis

Interventions

Intervention 1: Intervention group: take 1 gram L carnitin syroup for 3 months. Intervention 2: Control group: patients do not recieve carnitin supplement or drug.

Treatment - Drugs

Intervention group: take 1 gram L carnitin syroup for 3 months.

Control group: patients do not recieve carnitin supplement or drug.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients on hemodialysis in last year; age older than 21 years old and did not take antibiotics; vitamin C, vitamin E, carnitine during last 8 weeks. Exclusion criteria: if a patients suffering from an infection diease or fever in last month or is taking antibiotics.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Leptin. Timepoint: Baseline, end of thirth month. Method of measurement: ELISA.;Adiponectin. Timepoint: Baseline, end of thirth month. Method of measurement: ELISA.;Total anti oxidant capicity. Timepoint: Baseline, end of thirth month. Method of measurement: ELISA.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedigheh Ahmadi

Yazd University of Medical Sciences

ahmadi.sedigheh@ymail.com; ahmadi_ahmad_982@ymail.com+98 74 2422 2900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026